Why Bevacizumab Could Be a Game-Changer for Advanced Ovarian Cancer Patients
Bevacizumab, a drug that targets blood vessel growth, is being looked at closely for its potential to help people with advanced ovarian cancer. This isn't just any study; it's based on real-world data from a German cancer registry, making it more relatable and practical. The focus is on patients with stage IIIB to IV epithelial ovarian and fallopian tube cancer who ...